Monopar Therapeutics ($MNPR) Insider Trading & Smart Money Activity
Monopar Therapeutics Inc. ($MNPR) has 2 insider trades and 4 analyst ratings on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($3.22M), net -$3.22M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 2
- Net insider $ (12 mo)
- -$3.22M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 4
MNPR insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 1 · $2.56M | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 1 · $659.39K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All MNPR insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Starr Christopher MDirector | Sell (Open-market sale) 10b5-1 | 8.40K sh | $659.39K | +7.7% | — | |||||
| Insider | Robinson ChandlerChief Executive Officer | Sell (Open-market sale) 10b5-1 | 29.06K sh | $2.56M | -12.2% | — | |||||
| Analyst | BTIG | Reiterates to buy | PT $117 | +2.8% | +23.8% | Read | |||||
| Analyst | BTIG | Reiterates to buy | PT $117 | +2.8% | +23.8% | Read | |||||
| Analyst | HC Wainwright | Reiterates to buy | PT $105 | +2.7% | +13.6% | Read | |||||
| Analyst | HC Wainwright | Reiterates to buy | PT $105 | +2.7% | +13.6% | Read |
1W / 1M / 6M = how MNPR moved from the trade or filing date.
Insider trading in MNPR: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Starr Christopher M | Director | 1 | -$659.39K | Oct 1, 2026 | |
| Robinson Chandler | Chief Executive Officer | 1 | -$2.56M | Sep 24, 2026 |
Analyst ratings on MNPR
Frequently asked questions
Are MNPR insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $3.22M, a net -$3.22M.
What is the latest insider trade in MNPR?
Starr Christopher M, Director filed a sell (open-market sale) of 8.40K sh worth $659.39K on Oct 1, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.